-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Synaptope-related protein 25 (SNAP-25) in cerebrospinal fluid (CSF) is an emerging synaptic biomarker for the early diagnosis
of Alzheimer's disease (AD).
To this end, scholars from Germany have developed a new, sensitive ELSA for measuring SNAP-25 in CSF
.
The results showed that SNAP-25 CSF concentrations were elevated in AD and CJD (P<0.
In summary, the applicability of SNAP-25 as an early synaptic biomarker for AD and CJD may have prognostic value
for patients with CJD.
References:
CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer’s disease.